Biotech · Private company
HighField Biopharmaceuticals Corporation
Track this companyFree. Adds HighField Biopharmaceuticals Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- HF158K1 / 1.4 g lipid dosePhase 1 · Solid Tumors, AdultClinicalTrials.gov · fetched Nov 12, 2026
- HF158K1 / 2.2 g lipid dosePhase 1 · Solid Tumors, AdultClinicalTrials.gov · fetched Nov 12, 2026
- HF158K1 / 2.9 g lipid dosePhase 1 · Solid Tumors, AdultClinicalTrials.gov · fetched Nov 12, 2026
- HF1K16Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- HF158K1 in Patients With HER-2 Expressing Advanced Solid TumorsPHASE1 · RECRUITING · started Dec 12, 2023ClinicalTrials.gov NCT05861895 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability and PK of HF1K16 in Healthy VolunteersPHASE1 · COMPLETED · started Mar 20, 2021ClinicalTrials.gov NCT05386823 · fetched Nov 12, 2026